HAILEE MARTIN: Open Payments
NPI 1255080453 · HAMPSTEAD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 39 payments from 17 companies in 2025. Trend: 2023 $853 · 2024 $1,230 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $180 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $116 |
| AstraZeneca Pharmaceuticals LP | 3 | $76 |
| Amgen Inc. | 4 | $59 |
| ABBVIE INC. | 2 | $46 |
| Corcept Therapeutics | 2 | $35 |
| Abbott Laboratories | 2 | $33 |
| Exact Sciences Corporation | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: XIFAXAN, Wegovy, QULIPTA, OTEZLA, BREZTRI, Ozempic, Korlym, FARXIGA.
Industry payments across NC — which companies pay providers there.
